Governor 'is recovering'

Governor 'is recovering'

Samut Sakhon governor Verasak Vichitsangsri is making a fine recovery from Covid-19 and his lung capacity is almost back to normal, according to Prasit Watanapa, dean of the Faculty of Medicine at Siriraj Hospital.

Mr Verasak was confirmed to have contracted Covid-19 on Dec 27, about a week after his province saw a spike in cases, mostly among migrant workers.

"His latest lung X-ray shows an improvement of 80-90% from the first one, which was white because his lungs were filled [with fluid]. Now his lungs are nearly back to normal," Dr Prasit said, adding he was satisfied with the governor's blood-oxygen level.

Mr Verasak no longer requires antibiotics and his regimen of anti-inflammatory drugs has been reduced, the doctor said, explaining that the drugs were being fed to him orally through a tube.

His reliance on sleeping pills has also reduced, Dr Prasit said, as has his dependence on a ventilator, but he would eventually need to undergo physical therapy to rehabilitate his muscles.

The governor still cannot talk because he still needs suction tubes and is not yet able to cough up mucus on his own, Dr Prasit said. He did not say how long the governor, whose province has been hit hard by the pandemic, would have to stay in hospital.

Do you like the content of this article?

More Covid cases in Ayutthaya

AYUTTHAYA: Nineteen more coronavirus infections have been confirmed in Ayutthaya province, with most catching the virus from other confirmed cases, lifting the provincial total to 454.


US backs vaccine patent waiver

WASHINGTON: The United States threw its weight behind a waiver on patent protections for Covid-19 vaccines as India Thursday posted record deaths and infections from a catastrophic wave swamping the country.


Official assures foreigners they will get vaccines

A high-ranking official has confirmed that authorities plan to include 3 million foreigners living in the country in its mass vaccination programme to protect the entire population, amid concerns over the scope of vaccine access.